Sampre Nutritions Allots 2.9 Lakh Equity Shares To Promoter on Warrant Conversion; Share Price in Focus

Sampre Nutritions Limited has completed the allotment of 2,90,000 equity shares on September 25, 2025, following the conversion of warrants initially issued on a preferential basis. This development follows the company’s strategic capital-raising move as approved by shareholders in December 2023 and aligns with regulatory approvals obtained from BSE.

Preferential Allotment of 2.9 Lakh Shares to Promoter

The Board of Directors approved the issuance of 2,90,000 equity shares of face value ₹10 each at an issue price of ₹60.50 per share, upon the conversion of warrants held by promoter Meera Gurbani. These warrants were originally allotted on November 13, 2024, and the final payment of ₹45.375 per warrant was received in full, aggregating to ₹1,31,58,750.

This conversion marks the completion of all 8,40,000 warrants initially allotted, with no pending conversions remaining as of September 25, 2025.

Paid-Up Capital and Shareholding Structure Post Allotment

Following the allotment, Sampre Nutritions' paid-up equity share capital has increased from ₹21,55,68,550 to ₹21,84,68,550. The total number of outstanding equity shares now stands at 2,18,46,855.

Post-conversion, Meera Gurbani’s shareholding rose from 5,30,762 shares (7.73%) to 8,20,762 shares. However, due to the expanded capital base, her overall holding reduced to 3.76%.

Read More: Bonus Share Update: Sampre Nutritions Retains 1:1 Ratio, Face Value Revised to ₹5!

Key Transaction Details and Compliance

This was a single-investor transaction involving a promoter under a preferential allotment route. Allotted shares rank pari passu with the existing equity shares in all respects. The transaction complies with SEBI’s Master Circular dated November 11, 2024, and Listing Regulations under Regulation 30.

The issue was initially subscribed with 25% payment at ₹15.125 per warrant, and the remaining 75% was settled during the conversion, making it a fully compliant and completed capital raising exercise.

Sampre Nutritions Share Price Performance

On September 29, 2025, Sampre Nutritions share price opened at ₹118.65 on BSE, above the previous close of ₹116.58. During the day, it surged to ₹118.91 and dipped to ₹118.65. The stock is trading at ₹118.91 as of 11:18 AM hitting the upper circuit. The stock registered a gain of 2.00%.

Over the past week, it has moved up by 10.39%, over the past month, it has moved up by 51.44%, and over the past 3 months, it has moved up by 252.22%.

Conclusion

Sampre Nutritions’ successful warrant conversion and equity allotment strengthens its capital base, demonstrating effective capital management. With all 8,40,000 warrants now fully converted, the company concludes this fundraising initiative as per SEBI norms.

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.